HITI
High Tide Inc
NASDAQ · Pharmaceuticals
$2.35
+0.08 (+3.52%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 121.78M | 117.29M | 114.78M |
| Net Income | 15.16M | 15.94M | 14.39M |
| EPS | — | — | — |
| Profit Margin | 12.5% | 13.6% | 12.5% |
| Rev Growth | +0.5% | +17.8% | -7.5% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 135.58M | 135.37M | 127.81M |
| Total Equity | 98.13M | 102.75M | 99.11M |
| D/E Ratio | 1.38 | 1.32 | 1.29 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 21.06M | 20.19M | 19.55M |
| Free Cash Flow | 15.93M | 10.06M | 12.39M |